FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.
FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”
NCI Says Sponsored Meetings Must Be Held In Smoke-Free Localities As of Jan. 1.
ACS Presents Awards To Anti-Tobacco Activists.
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - Group chairs propose funding strategy to jump-start correlative studies
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS